Combination Veltuzumab and Fractionated 90Y- Epratuzumab Radioimmunotherapy in Follicular Lymphoma
Clinical trial NCT01147393 · TERMINATED
Trial details
- NCT number
- NCT01147393
- Sponsor
- Weill Medical College of Cornell University
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2013-08-06
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.